Abstract
To determine whether a correlation exists between polymorphisms of oxidative drug metabolism and dietary preference, 29 poor metabolizers of dextromethorphan, 18 poor metabolizers of mephenytoin and 134 extensive metabolizers of both drugs were screened for their preferences for various food items. Poor metabolizers of dextromethorphan showed a diminished stated preference for cauliflower and coconut, and poor metabolizers of mephenytoin showed a diminished stated preference for spinach and cabbage.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ames B. N., Magaw R., Gold L. S. Ranking possible carcinogenic hazards. Science. 1987 Apr 17;236(4799):271–280. doi: 10.1126/science.3563506. [DOI] [PubMed] [Google Scholar]
- Cohen C., Reinhardt B., Parry D. A., Roelants G. E., Hirsch W., Kanwé B. Alpha-helical coiled-coil structures of Trypanosoma brucei variable surface glycoproteins. Nature. 1984 Sep 13;311(5982):169–171. doi: 10.1038/311169a0. [DOI] [PubMed] [Google Scholar]
- Guengerich F. P., Distlerath L. M., Reilly P. E., Wolff T., Shimada T., Umbenhauer D. R., Martin M. V. Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation. Xenobiotica. 1986 May;16(5):367–378. doi: 10.3109/00498258609050245. [DOI] [PubMed] [Google Scholar]
- Guttendorf R. J., Britto M., Blouin R. A., Foster T. S., John W., Pittman K. A., Wedlund P. J. Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism. Br J Clin Pharmacol. 1990 Apr;29(4):373–380. doi: 10.1111/j.1365-2125.1990.tb03653.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Idle J. R., Mahgoub A., Sloan T. P., Smith R. L., Mbanefo C. O., Bababunmi E. A. Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer. Cancer Lett. 1981 Feb;11(4):331–338. doi: 10.1016/0304-3835(81)90099-9. [DOI] [PubMed] [Google Scholar]
- Inaba T., Jurima M., Mahon W. A., Kalow W. In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase. Drug Metab Dispos. 1985 Jul-Aug;13(4):443–448. [PubMed] [Google Scholar]
- La Du B. N., Jr The role of genetics in idiosyncratic reactions or adverse reactions to foods. World Rev Nutr Diet. 1990;63:209–219. doi: 10.1159/000418510. [DOI] [PubMed] [Google Scholar]
- Law M. R., Hetzel M. R., Idel J. R. Debrisoquine metabolism and genetic predisposition to lung cancer. Br J Cancer. 1989 May;59(5):686–687. doi: 10.1038/bjc.1989.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McManus M. E., Boobis A. R., Minchin R. F., Schwartz D. M., Murray S., Davies D. S., Thorgeirsson S. S. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes. Cancer Res. 1984 Dec;44(12 Pt 1):5692–5697. [PubMed] [Google Scholar]
- Scadding G. K., Ayesh R., Brostoff J., Mitchell S. C., Waring R. H., Smith R. L. Poor sulphoxidation ability in patients with food sensitivity. BMJ. 1988 Jul 9;297(6641):105–107. doi: 10.1136/bmj.297.6641.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wedlund P. J., Aslanian W. S., McAllister C. B., Wilkinson G. R., Branch R. A. Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism. Clin Pharmacol Ther. 1984 Dec;36(6):773–780. doi: 10.1038/clpt.1984.256. [DOI] [PubMed] [Google Scholar]
- Wolff T., Distlerath L. M., Worthington M. T., Guengerich F. P. Human liver debrisoquine 4-hydroxylase: test for specificity toward various monooxygenase substrates and model of the active site. Arch Toxicol. 1987;60(1-3):89–90. doi: 10.1007/BF00296955. [DOI] [PubMed] [Google Scholar]